U.S. Spirometer Market Size, Share & COVID-19 Impact Analysis, By Product Type (Devices, Software, and Accessories & Consumables), By Type (Volume Measurement and Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Others), By End User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, and Other Facilities), and Country Forecast, 2023-2030

The U.S. spirometer market size was worth USD 262.3 million in 2022 and is projected to grow at a CAGR of 5.8% during the forecast period. 

Spirometer is a diagnostic device used to perform basic lung function test for the diagnosis of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders.

The U.S. has seen a substantial increase in the prevalence of these respiratory conditions and government authorities are actively focused on reducing the economic burden of these diseases. Moreover, the market players are focused on introducing technologically advanced devices and software to enhance the diagnosis rate of these diseases, which is anticipated to surge the demand for these products across the country.

• According to the National Center for Health Statistics 2023, approximately 26 million people in the U.S. have asthma, which is 1 in 13 people. Out of these people, 21 million aged 18 and older, are living with asthma.

In addition, there are devices such as incentive spirometers that measure the volume of air inhaled during inspiration and are easily used in pulmonary rehabilitation. The availability of products with wide application is expected to drive its adoption rate among the patient population with respiratory diseases. Moreover, the rising prevalence of respiratory diseases is expected to surge the demand for early diagnosis, subsequently driving the demand for diagnostic devices such as incentive spirometers.

The outbreak of the COVID-19 pandemic negatively impacted the market, as restrictions imposed by regulatory authorities led to disruption in the supply chain of medical devices across the country.

U.S. Spirometer Market Trends

Growing Investment Opportunities for Introducing Accurate Devices

The need for precise devices to assess lung function is increasing, prompting the major players to focus on investing in the development of refined devices. Numerous established players and emerging start-ups are seeking funding to conduct research and hospital & clinical testing of pulmonary testers.

Government and private entities are collaborating with research institutions and startups to develop respiratory spirometers for the treatment and diagnosis of respiratory conditions, including chronic obstructive pulmonary disease and asthma.

• In January 2023, Aluna, offered an at-home spirometer and lung health management platform, received a USD 15.3 million Series B round of financing. This funding aimed to facilitate the expansion of its solution for patients managing asthma, cystic fibrosis, and chronic obstructive pulmonary disease.

U.S. Spirometer Market Growth Factor

Rising Prevalence of Chronic Obstructive Pulmonary Disease to Propel the Device Demand in the Country

Several factors contribute to the growing prevalence of this disease, such as tobacco smoking, air pollution, exposure to biomass fuel, and others. Government authorities are actively monitoring the prevalence data and are taking preventive measures to reduce frequent exposure to these factors, alleviating the burden of this disease. The growing emphasis on timely diagnosis is expected to surge the diagnosis rate and demand for diagnostic products, subsequently driving the U.S. market growth during the forecast period.

• As per an article published by the American Lung Association in February 2023, the estimated prevalence of chronic obstructive pulmonary disease (COPD) in the U.S. is approximately 9 million adults. However, the number is likely significantly higher, considering an estimated 18 million adults with evidence of lung dysfunction and diagnosed chronic obstructive pulmonary disease. The growing concern related to the prevalence of this disease is anticipated to surge its diagnosis rate. This is anticipated to drive the demand for diagnostic devices including spirometers during the forecast period.

According to the American Lung Association 2023 publication, more than 34 million Americans live with chronic lung diseases such as asthma and chronic obstructive pulmonary disease, which includes emphysema and chronic bronchitis.

RESTRAINING FACTORS

Lack of Skilled Professionals to Limit Device Adoption

Despite the increased prevalence of asthma and chronic obstructive pulmonary disease, certain barriers exist to the uptake of such devices. One of these barriers is the lack of qualified personnel for performing diagnostic tests, which is expected to impede market growth. There is a lack of awareness or proper training offered to healthcare professionals in managing such devices.

However, the Occupational Safety and Health Administration (OSHA) developed a guidance document to update the medical community on the required components for valid tests and strategies for interpreting results so that occupational spirometry tests are usable and of high technical quality.

U.S. Spirometer Market Segmentation Analysis

By Product Type Analysis

By product type, the market is segmented into devices, software, and accessories & consumables.

The devices segment dominated the market in 2022. The strong focus of market players in accelerating research activities to introduce technologically advanced products for the diagnosis of respiratory diseases is surging the demand for diagnostic devices. Moreover, the availability of a broad range of diagnostic devices for homecare settings is surging its adoption rate, subsequently driving the segment’s growth.

• In August 2023, The Med Company B.V. collaborated with Sananet Care B.V. to integrate the Spirobank Smart Spirometer in the MedCor4U App to revolutionize lung function tests.

By Type Analysis

On the basis of type, the U.S. market is divided into volume measurement and peak flow meters.

In 2022, the volume measurement devices segment held a dominant share of the U.S. spirometer market share. This is due to its ability to produce precise results with ease of use. The advantages offered by these devices are expected to increase their adoption for diagnosing respiratory conditions such as asthma and cystic fibrosis.

• In April 2021, CMI Health introduced SpiroLink, a digital home-use spirometer, equipped with a pressure sensor that allows the measurement of Peak Expiratory flow (PEF), Forced Expiratory volume (FEV1), and Forced Vital capacity (FVC). This technology reduces the risk of damage caused by debris, dirt, and mucus that can be expelled into the spirometer while in use, thus increasing the longevity and durability of the device.

By Application Analysis

In terms of application, the market is classified into chronic obstructive pulmonary disease (COPD), asthma, and others.

The increasing prevalence of chronic obstructive pulmonary disease segment led to its dominance in 2022. The comparatively higher sensitivity offered by spirometry devices in the diagnosis of respiratory conditions is expected to surge its demand during the forecast period. Moreover, the growing awareness and emphasis on timely diagnosis for respiratory diseases including COPD, is anticipated to surge the demand for these devices during the forecast period.

• According to the Centers for Disease Control and Prevention Data published in 2022, chronic obstructive pulmonary disease affects more than 15 million in the U.S., and more than half of these are women. This condition is a major cause of disability and the fourth leading cause of death in the U.S.

By End User Analysis

Based on end user, the market is segmented into diagnostic centers, hospitals, physicians/primary care offices or clinics, homecare settings, and other facilities.

The hospitals segment held a dominant share of the U.S. market in 2022. The segment's growth is attributed to the increasing hospital admission rate for critical respiratory conditions. This led to a surge in the demand for devices required for diagnosis and monitoring of respiratory conditions.

• According to the Asthma and Allergy Foundation of America, asthma accounted for 94,560 discharges from the U.S. hospital inpatient care and approximately 1 million emergency department visits in 2020.

KEY INDUSTRY PLAYERS

The market is highly consolidated due to the availability of a wide range of products and the extensive distribution network of the companies in the U.S. market. Leading players such as NdmediTechnik AG and COSMED Srl, have established their presence in the U.S. market by introducing innovative products. Another player, MGC Diagnostics, has also established a strong distribution channel across the country.

The strategic partnerships between the key players to introduce portable spirometers are expected to contribute to the expansion of the market. Additionally, Morgan Scientific and companies such as SCHILLER and VyAIRE Medical have entered the competition with new advanced spirometry devices and software.

LIST OF KEY COMPANIES PROFILED:

• ndd Medizintechnik AG (Switzerland)


• COSMED srl (Italy)


• MGC Diagnostics Corporation (U.S)


• Morgan Scientific (U.S)


• VYAIRE (U.S)


• Ganshorn Medizin Electronic GmbH (Germany)


• Medical International Research (MIR) (Italy)

KEY INDUSTRY DEVELOPMENTS:

• September 2022 – RxCap, Inc., partnered with ZEPHYRx to integrate cloud spriometry into RxCap’s remote monitoring platform.


• June 2021 – Albion received a 12 million Series A investment for its NuvoAir, a Bluetooth-enabled spirometer that remotely monitors lung function and feeds data into its advanced chronic disease management platform.


• April 2021 – Vitalograph launched Pneumotrac spirometer in the U.S., offering a potent respiratory diagnostic tool catering to both adults and pediatrics.

REPORT COVERAGE

The market report provides a detailed market analysis. It focuses on key aspects such as the prevalence of respiratory disorders and an overview of regulatory scenarios in the U.S. In additional, it includes key industry developments, new product launches, and the impact of COVID-19 on the market. Besides this, the report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the market growth over recent years.

Report Scope & Segmentation